您的位置: 首页 > 农业专利 > 详情页

ANTI-TUMOUR RESPONSE TO MODIFIED SELF-EPITOPES
专利权人:
SCANCELL LIMITED
发明人:
Linda Gillian Durrant,Victoria Anne Brentville,Rachael Louise Metheringham
申请号:
US16007944
公开号:
US20180346537A1
申请日:
2018.06.13
申请国别(地区):
US
年份:
2018
代理人:
摘要:
Anti-tumour immune responses to modified self-epitopes. The present invention relates to the use of tumour-associated epitopes in medicine and in particular in the treatment of cancer. The epitopes stimulate an immune reaction against the tumour and have a modification selected from deimination of arginine to citrulline, nitration of tyrosine, oxidation of tryptophan and deamination of glutamine or asparagine. The invention also relates to nucleic acids comprising sequences that encode such epitopes for use in the treatment of cancer.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充